heparin – Page 16 – Communicable Diseases Research

Impact of low molecular weight heparin administration on the clinical course of the COVID-19 disease

Article

Published on 2021-02-262022-10-29
Journal: Turkish Journal of Medical Sciences [Category] COVID-19, MERS,

Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities

Review

Published on 2021-02-252022-10-28
Journal: Pharmaceutics [Category] COVID-19,

Comprehensive Landscape of Heparin Therapy for COVID-19

COVID-19에 대한 헤파린 요법의 종합적인 전망

Review

Published on 2021-02-152022-09-11
Journal: Carbohydrate polymers [Category] SARS, 치료제,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition administration adverse effect adverse effects Anti-inflammation Anti-inflammatory Anticoagulant anticoagulant agent anticoagulation antiviral activities antivirus binding biochemical caused cells clinical clinical observation clinical observations Comprehensive concerning coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 disease Effect Effectiveness Evidence heparin in vitro study Infection landscape observation pandemic coronavirus pharmacological mechanism Protein public health emergency pulmonary thrombosis respiratory SARS-CoV-2 SARS-COV-2 infection severe acute respiratory syndrome Coronavirus Spike protein systemic symptom systemic symptoms the Spike therapy thrombosis Viral viral infection
[DOI] 10.1016/j.carbpol.2020.117232 PMC 바로가기 [Article Type] Review

Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders

COVID-19 관련 지혈 장애에서 레스베라트롤의 치료 가능성

Review

Published on 2021-02-062022-09-12
Journal: Molecules [Category] 진단,

[키워드] abnormal coagulation aggregation Anti-inflammatory anti-inflammatory properties anti-thrombotic property appear circulating Coagulation coagulation cascade coagulation disorder coagulation disorders Comorbidities Comorbidity Compound condition contributing to COVID-19 COVID-19 patients Cytokines disorders Effect elevated Endothelial cell endothelial cells endotheliopathy expected Factor fruits hallmark Hemostasis Hemostatic heparin Inflammation Inflammatory cytokine Inflammatory cytokines involved LMWH low molecular weight low molecular weight heparin modulate modulating Mortality outcome outcomes parameter patient mortality plant Platelet platelet activation Platelets Potential Prevent reduce resveratrol risk factor Risk factors SARS-COV-2 infection severe COVID-19 severity shown systemic inflammatory response Therapeutic approach therapeutic strategy thrombosis thrombotic Thrombotic events Treatment treatment of COVID-19 Vascular virtue
[DOI] 10.3390/molecules26040856 PMC 바로가기 [Article Type] Review

SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19

SAveRUNNER: 약물 용도 변경을 위한 네트워크 기반 알고리즘 및 COVID-19에 적용

Research Article

Published on 2021-02-052022-09-02
Journal: PLoS Computational Biology [Category] MERS, 신약개발, 임상, 치료제,

[키워드] (hydroxychloroquine Algorithm anti-IL6 anti-TNF applied Arthritis association cardiovascular diseases Chloroquine Clinical practice combination therapy Comorbidity coronavirus Coronavirus infections COVID-19 COVID-19 treatment COVID-19 treatments de novo disease disease-causing downstream drug Drug discovery drug target drugs effective drug effective drugs Efficiency enrichment analysis experiments Focusing gene set enrichment analysis Genetic heparin HIV human coronavirus Hydroxychloroquine in-silico include inhibitors knowledge lAbel lack Lopinavir malaria monoclonal antibodies monoclonal antibody network off-label Potential treatment predict Protein reduce Remdesivir remdesivir) repositioning rheumatoid arthritis rheumatoid arthritis) Ritonavir selected similarity thrombin Tocilizumab treat Vaccine variety worldwide pandemic
PMC 바로가기 [Article Type] Research Article

Association of anticoagulation dose and survival in hospitalized COVID-19 patients: A retrospective propensity score-weighted analysis

Multicenter Study

Published on 2021-02-012023-07-12
Journal: European journal of haematology [Category] SARS,

[키워드] anticoagulation COVID-19 heparin Novel coronavirus
[DOI] 10.1111/ejh.13533 PMC 바로가기 [Article Type] Multicenter Study

Aortic Arch Thrombus and Pulmonary Embolism in a COVID-19 Patient

COVID-19 환자의 대동맥궁 혈전 및 폐색전증

Case Reports

Published on 2021-02-012022-09-11
Journal: The Journal of emergency medicine [Category] 바이오마커,

[키워드] acute respiratory syndrome alteplase aortic arch aortic thrombus arch argatroban arterial thromboembolism Chest Chest radiography Computed tomography coronavirus coronavirus disease Coronavirus disease 2019 cough COVID-19 cytokine Cytokine storm D-dimer level distal Dyspnea elevated Embolism endothelial extremities Fever filling defects Ground-glass opacities healthy heparin hypercoagulable Hypercoagulable state hypercoagulable state. hypercoagulable states Infection Inflammation intensive care intensive care unit marker medical history moderate Mural normal past medical history patchy Patient positive pulmonary pulmonary arteries pulse oximetry respiratory resulting room air screened serum severe acute respiratory syndrome Coronavirus significantly subsegmental tested thromboembolic complications Thromboembolism Thrombus tomography treated unfractionated heparin venous viscera with COVID-19
[DOI] 10.1016/j.jemermed.2020.08.009 PMC 바로가기 [Article Type] Case Reports

Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations

Article

Published on 2021-02-012023-07-13
Journal: British Journal of Pharmacology [Category] SARS,

[키워드] COVID-19 heparin LMWH nebulised. SARS-CoV-2 UFH
[DOI] 10.1111/bph.15304 PMC 바로가기

Review of Medical Therapies for the Management of Pulmonary Embolism

Review

Published on 2021-01-262022-10-30
Journal: Medicina [Category] Coronavirus,

Spontaneous ilio-psoas haematomas (IPHs): a warning for COVID-19 inpatients

Observational Study

Published on 2021-01-252022-10-04
Journal: Annals of Medicine [Category] SARS, 임상,

[키워드] Admission anticoagulant therapy anticoagulation anticoagulation treatment case sery change Comorbidity COVID-19 Critically ill patient Evidence heparin Hospitalization hypercoagulability hypercoagulable Hypoesthesia hypovolaemia ICUs Ilio-psoas haematoma incidence increased risk indication Infection Inpatient Inpatients intensive care unit Italy lack lower limbs material molecular observation period optimal dose over Pain Pneumonia reduce regimen reported Result Rome SARS-COV-2 infection SARS-CoV-2 pneumonia serious complication Seven severe COVID-19 Spontaneous subject Symptom the cytokine storm the SARS-CoV-2 therapy thrombosis thrombotic risk Treatment triggered with COVID-19
[DOI] 10.1080/07853890.2021.1875498 PMC 바로가기 [Article Type] Observational Study